Search

Rita J Desai

Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1612, 1625
Total Applications
2152
Issued Applications
1290
Pending Applications
146
Abandoned Applications
716

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11032855 [patent_doc_number] => 20160229812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'SALT OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR CRYSTAL THEREOF, PHARMACEUTICAL COMPOSITION, AND FLT3 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/130168 [patent_app_country] => US [patent_app_date] => 2016-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11337 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15130168 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/130168
Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and FLT3 inhibitor Apr 14, 2016 Issued
Array ( [id] => 14097621 [patent_doc_number] => 20190090486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => MICROBIOCIDAL OXADIAZOLE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/091859 [patent_app_country] => US [patent_app_date] => 2016-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 538 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091859 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/091859
Microbiocidal oxadiazole derivatives Apr 7, 2016 Issued
Array ( [id] => 14699931 [patent_doc_number] => 10377698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-13 [patent_title] => Diphenethylamine derivatives which are inter alia useful as analgesics and method for their production [patent_app_type] => utility [patent_app_number] => 15/561614 [patent_app_country] => US [patent_app_date] => 2016-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14439 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561614 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/561614
Diphenethylamine derivatives which are inter alia useful as analgesics and method for their production Mar 29, 2016 Issued
Array ( [id] => 11010938 [patent_doc_number] => 20160207891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'MALIGNANT AND NON-MALIGNANT DISEASE TREATMENT WITH RAS ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 15/080995 [patent_app_country] => US [patent_app_date] => 2016-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11534 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080995 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/080995
Malignant and non-malignant disease treatment with Ras antagonists Mar 24, 2016 Issued
Array ( [id] => 12660220 [patent_doc_number] => 20180111906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => IMPROVED PROCESS FOR PREPARING A STATIN PRECURSOR [patent_app_type] => utility [patent_app_number] => 15/561977 [patent_app_country] => US [patent_app_date] => 2016-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5396 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561977 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/561977
IMPROVED PROCESS FOR PREPARING A STATIN PRECURSOR Mar 23, 2016 Abandoned
Array ( [id] => 12408363 [patent_doc_number] => 09969719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug [patent_app_type] => utility [patent_app_number] => 15/557210 [patent_app_country] => US [patent_app_date] => 2016-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30963 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557210 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/557210
Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug Mar 9, 2016 Issued
Array ( [id] => 11230892 [patent_doc_number] => 09458112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1' [patent_app_type] => utility [patent_app_number] => 15/060723 [patent_app_country] => US [patent_app_date] => 2016-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43494 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15060723 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/060723
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Mar 3, 2016 Issued
Array ( [id] => 13196005 [patent_doc_number] => 10112912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-30 [patent_title] => Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds [patent_app_type] => utility [patent_app_number] => 15/059232 [patent_app_country] => US [patent_app_date] => 2016-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 28 [patent_no_of_words] => 6273 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15059232 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/059232
Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds Mar 1, 2016 Issued
Array ( [id] => 12151461 [patent_doc_number] => 20180022723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'NOVEL COMPOUNDS FOR THE TREATMENT OF HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 15/551017 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38611 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551017 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/551017
Compounds for the treatment of hepatitis C Feb 18, 2016 Issued
Array ( [id] => 10987360 [patent_doc_number] => 20160184306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'Novel Pyrimidinyl-DiazoSpiro Compounds' [patent_app_type] => utility [patent_app_number] => 15/043920 [patent_app_country] => US [patent_app_date] => 2016-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36063 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043920 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/043920
Novel Pyrimidinyl-DiazoSpiro Compounds Feb 14, 2016 Abandoned
Array ( [id] => 11357317 [patent_doc_number] => 09533959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-03 [patent_title] => 'Methods of regioselective synthesis of 2,4-disubstituted pyrimidines' [patent_app_type] => utility [patent_app_number] => 15/043717 [patent_app_country] => US [patent_app_date] => 2016-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15448 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043717 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/043717
Methods of regioselective synthesis of 2,4-disubstituted pyrimidines Feb 14, 2016 Issued
Array ( [id] => 14031189 [patent_doc_number] => 10227333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-12 [patent_title] => Inhibition of OLIG2 activity [patent_app_type] => utility [patent_app_number] => 15/040948 [patent_app_country] => US [patent_app_date] => 2016-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74907 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040948 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/040948
Inhibition of OLIG2 activity Feb 9, 2016 Issued
Array ( [id] => 11901905 [patent_doc_number] => 09771329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-26 [patent_title] => 'Inhibitors of lysine specific demethylase-1' [patent_app_type] => utility [patent_app_number] => 15/018814 [patent_app_country] => US [patent_app_date] => 2016-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39851 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15018814 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/018814
Inhibitors of lysine specific demethylase-1 Feb 7, 2016 Issued
Array ( [id] => 12138410 [patent_doc_number] => 20180016493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'BLUE FLUORESCENT EMITTERS' [patent_app_type] => utility [patent_app_number] => 15/548774 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11921 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548774 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/548774
BLUE FLUORESCENT EMITTERS Feb 3, 2016 Abandoned
Array ( [id] => 12178631 [patent_doc_number] => 20180037568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-08 [patent_title] => 'MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/549265 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32526 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549265 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/549265
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Feb 3, 2016 Abandoned
Array ( [id] => 13424897 [patent_doc_number] => 20180263991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => COMPLEXES AND SALTS OF DIHYDROPYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN PHARMACEUTICALS [patent_app_type] => utility [patent_app_number] => 15/539147 [patent_app_country] => US [patent_app_date] => 2016-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539147 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/539147
Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals Jan 31, 2016 Issued
Array ( [id] => 12151445 [patent_doc_number] => 20180022710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE' [patent_app_type] => utility [patent_app_number] => 15/546885 [patent_app_country] => US [patent_app_date] => 2016-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10940 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546885 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/546885
ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE Jan 27, 2016 Abandoned
Array ( [id] => 12125020 [patent_doc_number] => 20180008605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'PTERIDINE DIONE MONOCARBOXYLATE TRANSPORTER INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/545152 [patent_app_country] => US [patent_app_date] => 2016-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19104 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545152 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/545152
Pteridine dione monocarboxylate transporter inhibitors Jan 21, 2016 Issued
Array ( [id] => 14119157 [patent_doc_number] => 10246423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Process for preparing statin precursor [patent_app_type] => utility [patent_app_number] => 15/545682 [patent_app_country] => US [patent_app_date] => 2016-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4312 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545682 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/545682
Process for preparing statin precursor Jan 21, 2016 Issued
Array ( [id] => 10791453 [patent_doc_number] => 20160137610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith' [patent_app_type] => utility [patent_app_number] => 15/001923 [patent_app_country] => US [patent_app_date] => 2016-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33320 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001923 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/001923
Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith Jan 19, 2016 Abandoned
Menu